Guindo Chirfi 4
4 · Merck & Co., Inc. · Filed May 2, 2024
Insider Transaction Report
Form 4
Guindo Chirfi
Chief Marketing Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-04-30+29,297→ 29,297 totalExercise: $129.22From: 2025-04-30Exp: 2034-04-29→ Common Stock (29,297 underlying)
Holdings
- 53.487(indirect: By 401(k))
Common Stock-401(k) Plan
- 20,753.241
Common Stock
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]The option vests and becomes exercisable in equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.